KR940000435A - 이미다졸릴 치환 시클로헥산 유도체 - Google Patents

이미다졸릴 치환 시클로헥산 유도체 Download PDF

Info

Publication number
KR940000435A
KR940000435A KR1019930011660A KR930011660A KR940000435A KR 940000435 A KR940000435 A KR 940000435A KR 1019930011660 A KR1019930011660 A KR 1019930011660A KR 930011660 A KR930011660 A KR 930011660A KR 940000435 A KR940000435 A KR 940000435A
Authority
KR
South Korea
Prior art keywords
carbon atoms
straight
less carbon
branched
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1019930011660A
Other languages
English (en)
Korean (ko)
Inventor
에. 뮬러 울리흐
드러셀 위그겐
페이 페테르
하. 한코 루돌프
휘브쉬 발테르
크레머 토마스
뮐러-글리만 마티아스
보익 마르틴
카즈다 스타니스라프
크노르 안드레아스
스타쉬 요하네스-페테르
볼파일 스테판
Original Assignee
클라우스 데너, 귄터 슈마허
바이엘 악티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 클라우스 데너, 귄터 슈마허, 바이엘 악티엔게젤샤프트 filed Critical 클라우스 데너, 귄터 슈마허
Publication of KR940000435A publication Critical patent/KR940000435A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/39—Unsaturated compounds containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/75—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of acids with a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
KR1019930011660A 1992-06-26 1993-06-25 이미다졸릴 치환 시클로헥산 유도체 Ceased KR940000435A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4221009A DE4221009A1 (de) 1992-06-26 1992-06-26 Imidazolyl-substituierte Cyclohexanderivate
DEP4221009.7 1992-06-26

Publications (1)

Publication Number Publication Date
KR940000435A true KR940000435A (ko) 1994-01-03

Family

ID=6461902

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930011660A Ceased KR940000435A (ko) 1992-06-26 1993-06-25 이미다졸릴 치환 시클로헥산 유도체

Country Status (22)

Country Link
US (1) US5508299A (enExample)
EP (1) EP0581003B1 (enExample)
JP (1) JPH0673016A (enExample)
KR (1) KR940000435A (enExample)
CN (2) CN1037512C (enExample)
AT (1) ATE196136T1 (enExample)
AU (1) AU666732B2 (enExample)
CA (1) CA2099078A1 (enExample)
CZ (1) CZ282309B6 (enExample)
DE (2) DE4221009A1 (enExample)
ES (1) ES2151891T3 (enExample)
FI (1) FI932952L (enExample)
HU (1) HUT64753A (enExample)
IL (1) IL106107A (enExample)
MX (1) MX9303599A (enExample)
NO (1) NO303825B1 (enExample)
NZ (1) NZ247974A (enExample)
PH (1) PH31425A (enExample)
RU (1) RU2110514C1 (enExample)
SK (1) SK281028B6 (enExample)
TW (1) TW245713B (enExample)
ZA (1) ZA934583B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW215434B (enExample) * 1992-03-07 1993-11-01 Hoechst Ag
HRP960015B1 (en) * 1995-02-01 2000-12-31 Bayer Ag Substituted indole derivatives
US5844318A (en) 1997-02-18 1998-12-01 Micron Technology, Inc. Aluminum film for semiconductive devices
DE19924818A1 (de) 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
AU2001267404A1 (en) * 2000-05-04 2001-11-12 Ipf Pharmaceuticals Gmbh Novel compounds for the treatment of inflammatory and cardiovascular diseases
WO2023274257A1 (zh) * 2021-07-01 2023-01-05 诸葛国琴 一种咪唑类化合物、其中间体及应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
KR950009860B1 (ko) * 1989-06-30 1995-08-29 이. 아이. 듀퐁 드 네모아 앤드 캄파니 융합된 환 아릴 치환된 이미다졸과 약제학적으로 허용되는 이의 염, 이들의 제조방법 및 이들을 함유하는 약제학적 조성물

Also Published As

Publication number Publication date
SK281028B6 (sk) 2000-11-07
CA2099078A1 (en) 1993-12-27
ATE196136T1 (de) 2000-09-15
JPH0673016A (ja) 1994-03-15
CN1037512C (zh) 1998-02-25
DE4221009A1 (de) 1994-01-05
EP0581003B1 (de) 2000-09-06
AU666732B2 (en) 1996-02-22
HUT64753A (en) 1994-02-28
CZ282309B6 (cs) 1997-06-11
CZ117393A3 (en) 1994-01-19
TW245713B (enExample) 1995-04-21
AU4146393A (en) 1994-01-06
IL106107A (en) 1997-09-30
IL106107A0 (en) 1993-10-20
MX9303599A (es) 1994-01-31
EP0581003A1 (de) 1994-02-02
DE59310098D1 (de) 2000-10-12
FI932952A7 (fi) 1993-12-27
FI932952A0 (fi) 1993-06-24
CN1182734A (zh) 1998-05-27
PH31425A (en) 1998-10-29
NO303825B1 (no) 1998-09-07
ES2151891T3 (es) 2001-01-16
CN1082538A (zh) 1994-02-23
RU2110514C1 (ru) 1998-05-10
US5508299A (en) 1996-04-16
FI932952L (fi) 1993-12-27
NZ247974A (en) 1996-07-26
ZA934583B (en) 1994-02-02
SK66893A3 (en) 1994-02-02
NO932133D0 (no) 1993-06-10
NO932133L (no) 1993-12-27
HU9301870D0 (en) 1993-09-28

Similar Documents

Publication Publication Date Title
KR940019708A (ko) 헤테로시클릭 치환된 페닐-시클로헥산-카르복실산 유도체
KR960029334A (ko) 2,9-이치환된 푸린-6-온
US20040002547A1 (en) Preparations of a sulfinyl acetamide
KR930023362A (ko) 술포닐벤질 치환 벤조피리돈 및 피리도피리돈
KR930019633A (ko) 치환 페닐아세트아미드
KR930007938A (ko) 시클릭 치환 이미다졸릴-프로펜산 유도체
RU2284329C2 (ru) Способ получения производных пенама из производных цефама
KR940000434A (ko) 이미다 졸릴 치환 페닐프로피온산 및 신남산 유도체
KR930019634A (ko) 이미다졸릴 치환 페닐아세트아미드
KR930007936A (ko) 이미다졸릴- 프로펜산 유도체
CA2367364C (en) Process for nitrating aniline derivatives
KR930021621A (ko) 프로페노일-이미다졸 유도체
JPS5917106B2 (ja) Ｎ−クロルホルミル−ｎ，ｎ’−二置換尿素誘導体の製法
EP1992619A1 (en) Process for preparing 2-(2-pyridylmethyl)-sulfinyl-1H-benzimidazoles and the intermediate compounds used therein
TH14766A (th) อนุพันธ์ไซโคลเอกเซนที่มีอิมิดาโซลอิลเข้าแทนที่
CN1036563A (zh) 4-卤代-3-氧代-2-烷氧亚氨基丁酸酯的制备方法
EP0257361B1 (en) 5-fluorouridine derivative and preparation of the same
KR970001473B1 (ko) 피라졸 설포닐클로라이드 유도체의 제조방법
KR100281593B1 (ko) 5-할로부틸-1-시클로헥실테트라졸의 제조방법
JP2896818B2 (ja) Ｌ−プロリン誘導体の製造法
US4683086A (en) Azido derivatives of pentaerythritol
CA2557731A1 (fr) Procede utile pour la preparation de benzazepines et derives de celles-ci
JPH06340623A (ja) ベンジルコハク酸誘導体の製造方法およびその製造中間体
KR930006198B1 (ko) 신규 α-클로로케톤 유도체 및 그 제조법
KR960701846A (ko) 안트라피라졸론 항암제를 합성하기 위한 중간물질 및 방법(intermediates and methods for the synthesis of anthrapyrazolone anticancer agents)

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19930625

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 19980408

Comment text: Request for Examination of Application

Patent event code: PA02011R01I

Patent event date: 19930625

Comment text: Patent Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20000229

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20000510

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20000229

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I